MoneyWorks4Me

Wockhardt informs about board meeting

29 Oct 2025 Evaluate

Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Wockhardt has informed that a meeting of the Board of Directors of the Company will be held on Monday, 3rd November, 2025, to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September, 2025. In view of the above, the trading window for dealing in the shares of the Company, which was closed from Wednesday, 1st October, 2025 shall remain closed until 48 hours after the declaration of Financial Results on 3rd November, 2025.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..